Don’t Miss TipRanks’ Half-Year Sale
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
- Make smarter investment decisions with TipRanks' Smart Investor Picks, delivered to your inbox every week.
Guardian Pharmacy Services, Inc. Class A ( (GRDN) ) has issued an announcement.
On May 20, 2025, Guardian Pharmacy Services, Inc. entered into stock purchase agreements with certain holders of its Class A common stock, which were initially issued as Class B shares during a corporate reorganization in September 2024. The company plans to buy back up to 1,457,365 shares in a private transaction using proceeds from a public offering, with the purchase price per share set at the public offering price minus the underwriting discount. This move is part of a strategic effort to manage stockholder agreements and market positioning, as it includes a 150-day lock-up period for holders post-purchase and supersedes previous lock-up agreements.
The most recent analyst rating on (GRDN) stock is a Buy with a $25.00 price target. To see the full list of analyst forecasts on Guardian Pharmacy Services, Inc. Class A stock, see the GRDN Stock Forecast page.
Spark’s Take on GRDN Stock
According to Spark, TipRanks’ AI Analyst, GRDN is a Neutral.
Guardian Pharmacy Services, Inc. presents a mixed picture. Strong revenue growth and positive guidance improve the outlook, yet significant profitability and leverage challenges remain. The technical analysis signals a short-term upward trend, but valuation is difficult to assess due to missing key metrics. Overall, the stock’s strengths in growth are countered by financial and valuation uncertainties, resulting in a moderate stock score.
To see Spark’s full report on GRDN stock, click here.
More about Guardian Pharmacy Services, Inc. Class A
Average Trading Volume: 93,914
Technical Sentiment Signal: Strong Buy
Current Market Cap: $1.68B
Find detailed analytics on GRDN stock on TipRanks’ Stock Analysis page.